Analysts Set Doximity, Inc. (NASDAQ:DOCS) Price Target at $28.82

Shares of Doximity, Inc. (NASDAQ:DOCSGet Free Report) have been given an average recommendation of “Hold” by the fourteen ratings firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $28.82.

Several brokerages have weighed in on DOCS. Evercore ISI reissued an “in-line” rating and set a $30.00 price objective on shares of Doximity in a report on Tuesday, April 2nd. JPMorgan Chase & Co. boosted their price objective on Doximity from $22.00 to $25.00 and gave the stock an “underweight” rating in a report on Friday, March 15th. Morgan Stanley reissued an “underweight” rating and set a $25.00 price objective on shares of Doximity in a report on Tuesday. Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a report on Monday, February 26th. Finally, SVB Leerink began coverage on Doximity in a report on Monday, February 26th. They set a “market perform” rating and a $32.00 price objective for the company.

Read Our Latest Report on DOCS

Doximity Stock Down 0.9 %

Doximity stock opened at $24.57 on Friday. The stock has a 50-day simple moving average of $27.33 and a 200 day simple moving average of $26.21. Doximity has a 12-month low of $19.71 and a 12-month high of $37.06. The stock has a market capitalization of $4.58 billion, a price-to-earnings ratio of 37.23, a P/E/G ratio of 3.10 and a beta of 1.17.

Doximity (NASDAQ:DOCSGet Free Report) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.06. The business had revenue of $135.28 million during the quarter, compared to analysts’ expectations of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. As a group, sell-side analysts anticipate that Doximity will post 0.72 EPS for the current year.

Insider Activity at Doximity

In related news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $26.97, for a total value of $67,425.00. Following the sale, the director now owns 10,258 shares in the company, valued at approximately $276,658.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 39.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Doximity

A number of large investors have recently added to or reduced their stakes in DOCS. First Horizon Advisors Inc. raised its stake in Doximity by 111.3% in the 4th quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after acquiring an additional 524 shares during the period. GAMMA Investing LLC bought a new stake in Doximity in the 4th quarter valued at $40,000. Creative Financial Designs Inc. ADV raised its stake in Doximity by 16.7% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after acquiring an additional 473 shares during the period. CWM LLC raised its stake in Doximity by 57.2% in the 3rd quarter. CWM LLC now owns 4,982 shares of the company’s stock valued at $106,000 after acquiring an additional 1,813 shares during the period. Finally, Neo Ivy Capital Management bought a new position in Doximity during the 3rd quarter worth $109,000. Institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

(Get Free Report

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.